| Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia J Perdomo, HHL Leung, Z Ahmadi, F Yan, JJH Chong, FH Passam, ... Nature communications 10 (1), 1322, 2019 | 365 | 2019 |
| Current concepts on the pathogenesis of the antiphospholipid syndrome B Giannakopoulos, F Passam, S Rahgozar, SA Krilis Blood 109 (2), 422-430, 2007 | 347 | 2007 |
| Protein disulfide isomerase inhibitors constitute a new class of antithrombotic agents R Jasuja, FH Passam, DR Kennedy, SH Kim, L van Hessem, L Lin, ... The Journal of clinical investigation 122 (6), 2104-2113, 2012 | 341 | 2012 |
| Pleural effusions in hematologic malignancies MG Alexandrakis, FH Passam, DS Kyriakou, D Bouros Chest 125 (4), 1546-1555, 2004 | 291 | 2004 |
| How we diagnose the antiphospholipid syndrome B Giannakopoulos, F Passam, Y Ioannou, SA Krilis Blood, The Journal of the American Society of Hematology 113 (5), 985-994, 2009 | 259 | 2009 |
| Levels of serum cytokines and acute phase proteins in patients with essential and cancer-related thrombocytosis MG Alexandrakis, FH Passam, IA Moschandrea, AV Christophoridou, ... American journal of clinical oncology 26 (2), 135-140, 2003 | 251 | 2003 |
| Monocyte tissue factor–dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin AP Owens, FH Passam, S Antoniak, SM Marshall, AL McDaniel, L Rudel, ... The Journal of clinical investigation 122 (2), 558-568, 2012 | 197 | 2012 |
| Naturally occurring free thiols within β2-glycoprotein I in vivo: nitrosylation, redox modification by endothelial cells, and regulation of oxidative stress–induced cell injury Y Ioannou, JY Zhang, FH Passam, S Rahgozar, JC Qi, B Giannakopoulos, ... Blood, The Journal of the American Society of Hematology 116 (11), 1961-1970, 2010 | 139 | 2010 |
| The clinical and prognostic significance of erythrocyte sedimentation rate (ESR), serum interleukin‐6 (IL‐6) and acute phase protein levels in multiple myeloma MG Alexandrakis, FH Passam, ES Ganotakis, K Sfiridaki, I Xilouri, ... Clinical & Laboratory Haematology 25 (1), 41-46, 2003 | 133 | 2003 |
| Quercetin-3-rutinoside inhibits protein disulfide isomerase by binding to its b′ x domain L Lin, S Gopal, A Sharda, F Passam, SR Bowley, J Stopa, G Xue, C Yuan, ... Journal of Biological Chemistry 290 (39), 23543-23552, 2015 | 105 | 2015 |
| Autoregulation of von Willebrand factor function by a disulfide bond switch D Butera, F Passam, L Ju, KM Cook, H Woon, C Aponte-Santamarķa, ... Science advances 4 (2), eaaq1477, 2018 | 98 | 2018 |
| Ki-67 proliferation index: correlation with prognostic parameters and outcome in multiple myeloma MG Alexandrakis, FH Passam, DS Kyriakou, K Dambaki, M Niniraki, ... American journal of clinical oncology 27 (1), 8-13, 2004 | 91 | 2004 |
| Elevated serum concentration of hepatocyte growth factor in patients with multiple myeloma: correlation with markers of disease activity MG Alexandrakis, FH Passam, A Sfiridaki, E Kandidaki, P Roussou, ... American journal of hematology 72 (4), 229-233, 2003 | 90 | 2003 |
| Beta 2 glycoprotein I is a substrate of thiol oxidoreductases FH Passam, S Rahgozar, M Qi, MJ Raftery, JWH Wong, K Tanaka, ... Blood, The Journal of the American Society of Hematology 116 (11), 1995-1997, 2010 | 89 | 2010 |
| Both platelet-and endothelial cell–derived ERp5 support thrombus formation in a laser-induced mouse model of thrombosis FH Passam, L Lin, S Gopal, JD Stopa, L Bellido-Martin, M Huang, ... Blood, The Journal of the American Society of Hematology 125 (14), 2276-2285, 2015 | 86 | 2015 |
| Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in … M Alexandrakis, F Passam, A Boula, A Christophoridou, G Aloizos, ... Annals of hematology 82, 19-23, 2003 | 86 | 2003 |
| Activated peripheral blood and endothelial cells in thalassemia patients D Kyriakou, M Alexandrakis, E Kyriakou, D Liapi, T Kourelis, F Passam, ... Annals of hematology 80, 577-583, 2001 | 84 | 2001 |
| Quantification of NETs‐associated markers by flow cytometry and serum assays in patients with thrombosis and sepsis KH Lee, L Cavanaugh, H Leung, F Yan, Z Ahmadi, BH Chong, F Passam International journal of laboratory hematology 40 (4), 392-399, 2018 | 79 | 2018 |
| Molecular pathophysiology of the antiphospholipid syndrome: the role of oxidative post‐translational modification of beta 2 glycoprotein I FH Passam, B Giannakopoulos, P Mirarabshahi, SA Krilis Journal of Thrombosis and Haemostasis 9, 275-282, 2011 | 78 | 2011 |
| Redox control of β2‐glycoprotein I–von Willebrand factor interaction by thioredoxin‐1 FH Passam, S Rahgozar, M Qi, MJ Raftery, JWH Wong, K Tanaka, ... Journal of thrombosis and haemostasis 8 (8), 1754-1762, 2010 | 75 | 2010 |
